뒤로
WuXi XDC Cayman Inc.(02268.HK) 가격
02268.HK 주가 차트
WUXI XDC (02268.HK)
WuXi XDC Cayman Inc.
HK$67.7
1.42%
$0.95
장 종료: Jan 21, 16:00:00 HKT
아직 데이터 없음Earnings FAQ
02268.HK의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
WuXi XDC Cayman Inc. 02268.HK의 지난 분기 매출 실적은 어땠나요?
WuXi XDC Cayman Inc.의 매출 추정치는 얼마인가요?
WuXi XDC Cayman Inc.의 수익 품질 점수는 얼마인가요?
WuXi XDC Cayman Inc.는 언제 수익을 보고하나요?
WuXi XDC Cayman Inc.의 예상 수익은 얼마인가요?
WuXi XDC Cayman Inc.은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$66.8
시가
$66.75
일일 범위
$66.3 - $68.55
52주 범위
$24.7 - $85.5
거래량
2.5M
평균 거래량
5.4M
EPS(TTM)
1.13
배당수익률
--
시가총액
$84.9B
WUXI XDC란 무엇인가요?
WuXi XDC Cayman, Inc. is an investment holding company, which engages in research, discovery, development, and manufacturing of the drug substances and drug products of antibody drug conjugates and other bio conjugates. The company is headquartered in Wuxi, Jiangsu and currently employs 2,270 full-time employees. The company went IPO on 2023-11-17. The firm's services include the discovery, process development and Good Manufacturing Practice (GMP) manufacturing for bioconjugates, monoclonal antibody intermediates and payload-linkers associated with bioconjugates. The firm provides CRDMO services to customers through contracts under fee-for-service (FFS) basis and contracts under full-time equivalent (FTE) basis. The firm principally conducts its businesses in domestic and overseas markets, including North America, Europe and the rest of the world.